Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2007-11-22
pubmed:abstractText
Rheumatoid arthritis (RA) is accompanied by increased resting energy expenditure (REE) and decreased fat-free mass (FFM). This is referred to as rheumatoid cachexia and is attributed to high levels of tumour necrosis factor-alpha (TNF-alpha). This study aimed to investigate the effects of anti-TNF-alpha therapy on REE, body composition, physical activity and protein intake in RA patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1462-0332
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1824-7
pubmed:meshHeading
pubmed-meshheading:18032540-Aged, pubmed-meshheading:18032540-Analysis of Variance, pubmed-meshheading:18032540-Antirheumatic Agents, pubmed-meshheading:18032540-Arthritis, Rheumatoid, pubmed-meshheading:18032540-Body Composition, pubmed-meshheading:18032540-Body Mass Index, pubmed-meshheading:18032540-Cachexia, pubmed-meshheading:18032540-Case-Control Studies, pubmed-meshheading:18032540-Energy Metabolism, pubmed-meshheading:18032540-Female, pubmed-meshheading:18032540-Humans, pubmed-meshheading:18032540-Male, pubmed-meshheading:18032540-Middle Aged, pubmed-meshheading:18032540-Probability, pubmed-meshheading:18032540-Prognosis, pubmed-meshheading:18032540-Reference Values, pubmed-meshheading:18032540-Risk Assessment, pubmed-meshheading:18032540-Treatment Outcome, pubmed-meshheading:18032540-Tumor Necrosis Factor-alpha
pubmed:year
2007
pubmed:articleTitle
Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.
pubmed:affiliation
School of Sport, Performing Arts and Leisure, University of Wolverhampton, Walsall, West Midlands, UK. gm@wlv.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't